Acutus Medical Inc (AFIB) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acutus Medical Inc   (AFIB)


Acutus Medical Inc's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Acutus Medical Inc's ROI in the fourth quarter of 2024?
Acutus Medical Inc recorded a cumulative net loss of $-10 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on investment (ROI) of -43.1%.

Within the Healthcare sector 562 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2024 quarter, so far to 4446, from total ROI ranking in the third quarter of 2024 at 4485.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM -69.01 % -70.53 % -59.1 % -48.43 % -34.98 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 16 18 23 32 35
Return On Investment (TTM) -43.1 % -156.06 % -123.94 % -122.4 % -114.24 %
AFIB's Overall Ranking # 4446 # 4485 # 4469 # 4547 # 5194
Seq. Investment Change TTM -17.51 % -32.81 % -26.95 % -23.46 % -21.55 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -10 -42 -50 -67 -82

AFIB Company Profile >> Back to AFIB Roi Comparisons >> See Annual AFIB Return On Investment



Return On Investment AFIB's Ranking
Within: No.
Industry # 138
Sector # 563
Overall # 4446

Return On Investment Statistics
High Average Low
-14.99 %
-73.92 %
-156.06 %
(Mar 31 2023)   (Sep 30 2024)







Financial Statements
Acutus Medical Inc's IV. Quarter Investments $ 16 Millions AFIB's Balance sheet
Acutus Medical Inc's IV. Quarter Income $ -1 Millions Quarterly AFIB's Income Statement
AFIB's Income by Division See AFIB's Income by Division


AFIB Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 16 35 114 151 171
Y / Y Investment Growth -53.71 % -69.17 % -24.93 % -11.34 % -
Net Income in Millions -10 -82 -40 -118 -102
Y / Y Net Income Growth - - - - -
Annual Return On Investment -58.9 % -233.2 % -34.88 % -77.79 % -59.77 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AFIB's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AFIB's Competitors
Subscribers only: Roi for Acutus Medical Inc's Suppliers
Subscribers only: Return On Investment for AFIB's Customers

Other Ratios
AFIB's Roa AFIB's Inventory Turnover Ratio AFIB's Growth Rates AFIB's Dividend Statistics
AFIB's Profitability Ratios AFIB's Asset Turnover Ratio AFIB's Dividend Growth
AFIB's Roe AFIB's Valuation Ratios AFIB's Financial Strength Ratios AFIB's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.